AFDO RAPS Healthcare Products Collaborative
BIO
Evoto

Sara

Coon

Director, Regulatory Affairs

Halozyme, Inc

Sara Coon leads Combination Product Regulatory strategies and submissions at Halozyme, Inc., bringing over 30 years of experience in the medical device and pharmaceutical industries. As a Regulatory Affairs Director, she has supported approvals of PMAs, IDEs, NDAs, MAFs, and 510(k)s. Her EU expertise includes implementing ISO 13485 compliant quality systems and preparing GSPR (formerly ER) checklists and Technical Dossiers for devices and combination products. With broad knowledge in Quality Systems and Regulatory Affairs, Sara is dedicated to ensuring the products she develops are safe and effective for the patients who depend on them.

2024 Combo Logo FDA

Back to agenda

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.

Newsletter

Stay in the know about upcoming events and breaking news from the collaborative.

Subscribe

ContACT

Have questions about our events or how to get involved with one of our committees or workgroups?

Get in touch

© 2024 AFDO/RAPS Healthcare Products Collaborative